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Background: Low blood levels of vitamin D (25-hydroxy D3, 25OHD3) in women have been associated with an
increased risk of several diseases. A large part of the population may have suboptimal 25OHD3 levels but high-risk
groups are not well known. The aim of the present study was to identify determinants for serum levels of 25OHD3
in women, i.e. factors such as lifestyle, menopausal status, diet and selected biochemical variables.
Methods: The study was based on women from the Malmö Diet and Cancer Study (MDCS), a prospective,
population-based cohort study in Malmö, Sweden. In a previous case–control study on breast cancer, 25OHD3
concentrations had been measured in 727 women. In these, quartiles of serum 25OHD3 were compared with
regard to age at baseline, BMI (Body Max Index), menopausal status, use of oral contraceptives or menopausal
hormone therapy (MHT) , life-style (e.g. smoking and alcohol consumption), socio-demographic factors, season,
biochemical variables (i.e. calcium, PTH, albumin, creatinine, and phosphate), and dietary intake of vitamin D and
calcium. In order to test differences in mean vitamin D concentrations between different categories of the studied
factors, an ANOVA test was used followed by a t-test. The relation between different factors and 25OHD3 was
further investigated using multiple linear regression analysis and a logistic regression analysis.
Results: We found a positive association between serum levels of 25OHD3 and age, oral contraceptive use,
moderate alcohol consumption, blood collection during summer/ autumn, creatinine, phosphate, calcium, and a
high intake of vitamin D. Low vitamin D levels were associated with obesity, being born outside Sweden and high
PTH levels.
Conclusions: The present population-based study found a positive association between serum levels of 25OHD3
and to several socio-demographic, life-style and biochemical factors. The study may have implications e. g. for
dietary recommendations. However, the analysis is a cross-sectional and it is difficult to suggest Lifestyle changes as
cause- effect relationships are difficult to assess.Background
Low blood levels of vitamin D (25-hydroxy D3,
25OHD3) in women have been associated with an in-
creased risk of hypertension [1], myocardial infarction
[2], sudden cardiac death [3], depression [4], diabetes
[5], obesity [6], fracture [7] and cancer [8,9]. However,
determinants of levels of 25OHD3 are not well known,
and few studies have examined the impact of lifestyle,* Correspondence: Leila.shirazi@med.lu.se
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reproduction in any medium, provided the orand menopausal status, dietary and biochemical factors
on vitamin D status. Furthermore, a large part of the
population in northern countries might suffer from sub-
optimal 25OHD3 levels because of inadequate exposure
to sunlight [10], due to geographical location [11], cul-
tural differences [12], and race [13,14].
Sun exposure plays a central role in vitamin D metab-
olism as vitamin D is formed in the skin under the influ-
ence of UV light [15], and there is a well-known
seasonal variation with lowest levels during the winter
[16]. The other source of vitamin D is from the diet, but
the association between dietary intake and serum
25OHD3 levels has not been extensively investigatedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Distribution of serum vitamin D quartiles in relation to reproductive history, life-style factors and season
Factor Serum vitamin D quartile [nmol/L]
1 [18–69] 2 [70–86] 3 [87–104] 4 [105–173] All
n = 179 n = 187 n = 177 n = 184 n = 727
Column percent*; mean (SD) in italics
Age (years) 56.2 (7.3) 56.2 (7.9) 58.1 (7.2) 57.2 (7.2) 56.9 (7.2)
≤50 27.9 23.5 18.1 19.6 22.3
>50 – ≤55 22.3 23.0 18.6 26.1 22.6
>55 – ≤60 19.0 20.3 21.5 16.8 19.4
>60 – ≤65 17.9 21.9 20.9 19.6 20.1
>65 12.8 11.2 20.9 17.9 15.7
BMI (kg/m2) 26.7 (4.96) 25.5 (4.5) 25.1 (3.4) 24.6 (3.4) 25.5 (4.2)
<20 5.0 6.4 4.5 6.5 5.6
≥20 – <25 39.1 44.9 48.6 52.2 46.2
≥25 – <30 34.6 34.2 40.1 33.7 35.6
≥30 21.2 14.4 6.8 7.6 12.5
Oral contraception
No 52.5 52.9 51.4 44.6 50.3
Yes 47.5 47.1 48.6 55.4 49.7
Menopausal status
Pre 30.7 26.7 21.5 23.9 25.7
Peri/post 69.3 73.3 78.5 76.1 74.3
MHT** (n = 537)
No 77.4 86.1 72.7 76.4 78.1
Yes 21.0 13.9 26.6 23.6 21.3
Smoking status
Never 40.8 43.3 42.9 41.3 42.1
Current 29.6 24.1 29.4 27.7 27.6
Ex 29.6 32.6 27.7 31.0 30.3
Alcohol consumption
Zero 11.7 6.4 7.9 5.4 7.8
<15 g/day 58.7 68.4 61.6 62.5 62.9
15 – 30 g/day 12.8 11.2 16.9 14.1 13.8
>30 g/day 3.9 1.1 2.8 3.3 2.8
Infrequent 12.8 12.8 10.7 14.7 12.8
Baseline season
Spring 43.6 25.1 27.1 14.1 27.4
Summer 14.5 22.5 31.1 43..5 27.9
Autumn 15.6 22.5 20.3 23.4 20.5
Winter 26.3 29.9 21.5 19.0 24.2
Education
O-level college 67.0 66.3 67.8 71.7 68.2
A-level college 10.1 7.0 7.9 6.5 7.8
University 22.9 26.7 24.3 21.7 23.9
Socio-economic index
Manual 39.1 35.8 35.6 40.2 37.7
Non-manual 53.1 51.3 59.9 53.8 54.5
Employer 7.3 12.8 4.5 6.0 7.7
Shirazi et al. BMC Women's Health 2013, 13:33 Page 2 of 13
http://www.biomedcentral.com/1472-6874/13/33
Table 1 Distribution of serum vitamin D quartiles in relation to reproductive history, life-style factors and season
(Continued)
Born in Sweden
Yes 83.2 91.4 93.8 92.9 90.4
No 16.8 8.6 6.2 7.1 9.6
* Due to missing values, percentages do not always add up to 100%. ** Only in peri/postmenopausal.
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socioeconomic factors and life-style; for instance low
vitamin D levels have been noted among low income
groups [18], and among individuals with heavy alcohol
consumption [19]. However, apart from this, few studies
have reported on vitamin D in relation to life-style and
menopausal status. Vitamin D metabolism is closely re-
lated to PTH, calcium and phosphate [20].
This study is based on data from the Malmö Diet and
Cancer Study (MDCS), a prospective, population-based
cohort study in Malmö, Sweden [21]. At baseline, 17,035
women answered a questionnaire on life-style, repro-
ductive life and socio-demographic factors. An import-
ant part of the examination was a dietary assessment
and collection of blood samples [22].
The aim of the present study was to identify determi-
nants for serum levels of 25OHD3 in women, i.e. factors
such as lifestyle, menopausal status, diet and selected
biochemical variables.
Methods
The malmö diet and cancer study
The Malmö Diet and Cancer Study (MDCS) is a pro-
spective, population-based cohort study in Malmö,
Sweden’s third largest city with about 300,000 inhabi-
tants. The main aim of the MDCS was to estimate the
potential association between dietary factors and malig-
nancy [23]. All women in Malmö born 1923–1950 were
invited and the baseline examination took place between
1991 and 1996. The majority of women were born in
Sweden or other Nordic countries. Finally, 17,035
women participated, corresponding to a participation
rate of approximately 40%.
Baseline examination
All participants completed a questionnaire on socio-
economic factors (e.g. education, occupation, country of
birth), life-style (e.g. smoking, alcohol consumption, use
of oral contraceptives (OC) and menstrual status), and
for women also menopausal status. Smoking status was
classified as current, never or ex-smoking. An open
ended question assessed use of medications. For the pur-
pose of the present analysis, menopausal hormone ther-
apy (MHT) was classified into two categories: non-users
and current users. Women were classified as pre- or
peri/ postmenopausal using information on previousgynaecologic surgery and last menstruation as previously
described in detail [24]. Anthropometric measurements
were performed and Body Mass Index (BMI) was calcu-
lated (kg/m2). BMI was classified as underweight <20,
normal weight ≥ 20 - <25, overweight ≥25 - <30, and
obesity ≥30. Season was classified as “spring” (March-
April), “summer” (May-August), “autumn” (September-
October) and “winter” (November-February), based on
the date of the baseline examination.
Dietary data
Dietary data was obtained through a modified diet his-
tory consisting of (a) a 168-item dietary questionnaire
for assessment of the consumption frequencies and por-
tion sizes of regularly eaten foods (i.e. sandwiches, cakes
and cookies, fruit, breakfast cereals, milk and yoghurt,
coffee, tea, candy, snacks etc.) and the general meal pat-
tern, (b) a 7 day menu-book for registration of cooked
lunch and dinner meals, cold beverages including alco-
hol, drugs, natural remedies and nutrient supplements,
and c) a one-hour diet history interview [25]. The food
intake information was converted to nutrient intake data
using the nutrient information available in the MDCS
Food and Nutrient Database. This database, specifically
developed for the MDCS, originates from PC KO ST2 -
93 of the Swedish National Food Administration. The
average daily intake of total energy and nutrients was
calculated. The procedure has been previously described
in detail [26]. The relative validity of the diet history
method has previously been examined with 18 days of
weighed food records collected during one year as the
reference [25]. In women, the energy-adjusted validation
correlation coefficients were for calcium 0.65 and for
total energy intake 0.54, when administrating the diet
history prior to the reference method.
This study examined the following nutrient variables:
total energy (kcal), vitamin D (μg) and calcium (mg).
Separate analyses were performed for intake related to
food, and total intake including supplements. In order to
adjust for energy, the residual method was applied using
log-transformed variables of total energy, vitamin D and
calcium intakes [26]. Four different variables were cre-
ated by regressing the log-transformed variables sepa-
rated on total energy intake: (1) vitamin D-dietary; (2)
vitamin D-total (i.e. dietary and supplement); (3)
calcium-dietary; and (4) calcium-total. The residuals
Table 2 Mean serum vitamin D levels in relation to
reproductive history, life–style factors and season





≤50 162 84.4 (80.3–88.6) Ref.
>50 – ≤55 164 88.6 (84.3–92.8) 0.10
>55 – ≤60 141 87.7 (83.0–92.5) 0.29
>60 – ≤65 146 88.5 (84.6–92.5) 0.13
>65 114 93.6 (88.3–98.9) 0.01 0.107
BMI (kg/m2)
<20 41 93.2 (83.6–102.8) 0.62
≥20 – <25 336 91.0 (88.1–93.9) Ref.
≥25 – <30 259 87.9 (84.6–91.1) 0.16
≥30 91 77.3 (71.7–82.9) <0.001 <0.001
Oral contraception
No 366 86.9 (84.2–89.5) Ref.
Yes 361 89.7 (86.8–92.6) 0.011 0.011
Menopausal status
Pre 187 85.0 (81.1–88.8) Ref.
Peri/Post 540 89.4 (87.1–91.7) 0.056 0.056
MHT** (n = 537)
No 422 89.2 (86.6–91.8) Ref.
Yes 115 90.8 (85.7–95.9) 0.57 0.27
Smoking status
Never 306 87.9 (85.0–90.8) Ref.
Current 201 87.3 (83.3–91.3) 0.813
Ex 220 89.7 (86.0–93.4) 0.443 0.635
Alcohol consumption
Zero 57 80.3 (72.8–87.8) Ref.
<15 g/day 457 88.9 (86.4–91.4) 0.025
15 – 30 g/day 100 89.5 (84.8–94.3) 0.032
>30 g/day 20 82.7 (66.3–99.1) 0.762
Infrequent 93 89.7 (83.9–95.5) 0.049 0.169
Baseline season
Spring 199 78.6 (74.8–82.4) Ref.
Summer 203 99.0 (95.2–102.7) <0.001
Autumn 149 89.6 (85.8–93.5) <0.001
Winter 176 85.7 (81.8–89.6) 0.011 <0.001
Education
O–level college 496 89.3 (86.9–91.7) Ref.
A–level college 57 83.4 (75.8–91.0) 0.128
University 174 87.0 (83.0–91.0) 0.324 0.236
Socio–economic index
Manual 274 89.0 (85.6–92.5) Ref.
Non–manual 396 88.5 (85.9–91.1) 0.796
Employer 56 83.9 (77.3–90.5) 0.221 0.158
Table 2 Mean serum vitamin D levels in relation to
reproductive history, life–style factors and season
(Continued)
Born in Sweden
Yes 657 89.3 (87.2–91.4) Ref.
No 70 78.6 (72.0 –85.3) 0.002 0.00
* Compared to reference (p–value). ** Only in peri/postmenopausal.
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gorized into five categories (quintiles). The limits for the
original variables were given for each quintile.
Alcohol consumption was divided into five categories:
zero, low (<15 g alcohol/day), medium (15-30 g alcohol/
day), high (>30 g alcohol/day), and infrequent use. The
amount per day was obtained from the menu book. Par-
ticipants with zero consumption in the menu book and
with no consumption during the previous thirty days or
previous year according to the questionnaire were cate-
gorized as zero consumers [27]. Participants with zero
consumption in the menu book but reporting alcohol
consumption during the previous thirty days or previous
year were regarded as infrequent users. For example a
glass of wine (12 centilitres) corresponds to 15 grams
pure alcohol.
Study population
The present study is based on data from female controls
from a previous nested case–control study within the
MDCS [22]. In that study, cases were women with inci-
dent breast cancer; controls were selected from MDCS
subjects at risk at the time of disease occurrence of the
case. Cases and controls were matched for age, calendar
time of blood sampling, and menopausal [28] status.
Out of 738 controls, 11 had no data on 25OHD3 con-
centrations and were excluded. Thus, the present study
is based on data from 727 women.
Blood samples and laboratory methods
Blood samples were drawn at baseline in non-fasting
subjects by a trained nurse and plasma and serum sepa-
rated within 1 hour. The samples were subsequently
stored in a biological bank at −80°C before analysis [23].
Serum was retrieved from un-thawed samples in the
MDCS bio-bank was analysed for 25OHD3, PTH, cal-
cium, phosphate, creatinine and albumin. 25OHD3 was
analysed with high pressure liquid chromatography
(HPLC) and PTH with the Immulite® 2000 Intact PTH
immunoassay (Diagnostic Products Corporation, Los
Angeles, CA). Total calcium was analysed by neutral
carrier ion-selective electrode [29], albumin by rate
immunonephelometry [28], phosphate by a colorimetric
method by complexing with ammoniummolybdate and
creatinine by the Jaffé method. These analyses were car-
ried out with the Synchron LX System (Beckman
Table 3 Crude and adjusted odds ratios (OR) for high (> 75 nmol/L) vs. low (≤75 nmol/L) vitamin D levels, and
regression coefficients (βi) from multiple regression analysis, in relation to reproductive history, life–styles factors and
season
Factor Low (n) High (n) Crude OR (95% CI) Adjusted*OR (95% CI) βi (95% CI) Adjusted* βi (95% CI)
Age (years)
≤50 59 103 1.00 1.00 Baseline Baseline
>50 – ≤55 53 111 1.20 (0.76–1.90) 1.18 (0.73–1.92) 4.13 (–1.78 to 10.0) 4.10 (–1.73 to 9.94)
>55 – ≤60 49 92 1.08 (0.67–1.72) 0.99 (0.60–1.64) 3.31 (–2.83 to 9.46) 2.25 (–3.84 to 8.33)
>60 – ≤65 42 104 1.42 (0.88–2.29) 1.49 (0.89–2.49) 4.12 (–1.97 to 10.2) 5.05 (–1.02 to 11.1)
>65 31 83 1.53 (0.91–2.59) 1.44 (0.84–2.48) 9.14 (2.61 to 15.7) 8.03 (1.73 to 14.3)
BMI (kg/m2)
<20 12 29 0.80 (0.45–1.86) 0.97 (0.46–2.04) 1.12 (–3.25 to 5.50) 1.47 (–2.73 to 5.68)
≥20– <25 92 244 1.00 1.00 Baseline Baseline
≥25– <30 82 177 0.26 (0.57–1.16) 0.79 (0.55–1.14) −1.55 (–3.74 to 0.63) −1.73 (–3.84 to 0.39)
≥30 48 43 0.34 (0.21–0.54) 0.31 (0.19–0.52) −6.84 (–9.97 to –3.72) −6.98 (–10.0 to –3.94)
Oral contraception
No 126 240 1.00 1.00 Baseline Baseline
Yes 108 253 1.23 (0.90–1.68) 1.49 (1.04–2.13) 2.84 (–1.13 to 6.80) 5.40 (1.17 to 9.62)
Menopausal status
Pre 67 120 1.00 1.00 Baseline Baseline
Peri/post 167 373 1.25 (0.88–1.77) 1.22 (0.70–2.12) 4.42 (–0.12 to 8.95) 3.62 (–3.10 to 10.3)
MHT** (n = 537)
No 135 287 1.00 1.00 Baseline Baseline
Yes 30 85 1.33 (0.84–2.12) 1.37 (0.85–2.23) −1.52 (–4.53 to 1.48) −1.55 (–4.50 to 1.40)
Smoking status
Never 97 209 1.00 1.00 Baseline Baseline
Ex 66 135 0.95 (0.65–1.39) 1.06 (0.71–1.58) −0.58 (–5.44 to 4.28) 0.85 (–3.91 to 5.62)
Current 71 149 0.97 (0.67–1.41) 1.03 (0.70–1.52) 1.81 (–2.93 to 6.54) 2.42 (–2.18 to 7.03)
Alcohol consumption
Zero 25 32 1.00 1.00 Baseline Baseline
<15 g/day 311 315 1.73 (0.99–3.03) 1.92 (1.07–3.45) 8.60 (1.10 to 16.1) 9.31 (2.05 to 16.6)
15 – 30 g/day 30 70 1.82 (0.93–3.58) 2.16 (1.06–4.41) 9.20 (0.34 to 18.1) 10.7 (2.03 to 19.3)
>30 g/day 8 12 1.17 (0.42–3.30) 1.44 (0.48–4.33) 2.38 (–11.5 to 16.3) 4.51 (–9.01 to 18.0)
Infrequent 29 64 1.72 (0.87–3.41) 2.01 (0.99–4.08) 9.41 (0.42 to 18.4) 10.9 (2.21 to 19.5)
Baseline season
Spring 95 104 1.00 1.00 Baseline Baseline
Summer 39 164 3.84 (2.46–6.00) 3.89 (2.48–6.12) 20.3 (15.2 to 25.5) 20.1 (14.9 to 25.2)
Autumn 39 110 2.58 (1.63–4.08) 2.52 (1.59–4.00) 11.0 (5.45 to 16.6) 10.5 (4.94 to 16.1)
Winter 61 115 1.72 (1.14–2.61) 1.71 (1.12–2.60) 7.04 (1.72 to 12.4) 6.80 (1.47 to 12.1)
Education
O–level college 158 338 1.00 1.00 Baseline Baseline
A–level college 23 34 0.69 (0.39–1.21) 0.70 (0.39–1.27) −5.87 (–13.3 to 1.61) −5.63 (–12.9 to 1.62)
University 53 121 1.07 (0.73–1.55) 1.17 (0.78–1.74) −2.31 (–7.02 to 2.40) −1.10 (–5.77 to 3.57)
Socio–economic index
Manual 93 181 1.00 1.00 Baseline Baseline
Non–manual 120 276 1.18 (0.85–1.64) 1.24 (0.88–1.75) −0.37 (–4.57 to 3.83) 0.20 (–3.87 to 4.27)
Employer 20 36 0.93 (0.51–1.69) 0.88 (0.47–1.65) −4.91 (–12.7 to 2.94) −4.97 (–12.6 to 2.62)
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Table 3 Crude and adjusted odds ratios (OR) for high (> 75 nmol/L) vs. low (≤75 nmol/L) vitamin D levels, and
regression coefficients (βi) from multiple regression analysis, in relation to reproductive history, life–styles factors and
season (Continued)
Born in Sweden
Yes 200 457 1.00 1.00 Baseline Baseline
No 34 36 0.46 (0.28–0.76) 0.44 (0.26–0.74) −10.6 (–17.3 to –3.96) −10.5 (–16.9 to –4.08)
* Adjusted for age, season and time in freezer. ** Only in peri/postmenopausal.
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25OHD3 8.5% at 70 nmol/L and 7.1% at 210 nmol/L, for
PTH 4% at 5.9 pmol/L and at 40.3 pmol/L, for calcium
2% at 2.00 mmol/L and at 3.10 mmol/L, for albumin 4%
at 25 g/L and 2% at 48 g/L, for creatinine 12% at
34 μmol/L and 4% at 129 μmol/L, and for phosphate 3%
at 0.66 mmol/L and 5% at 2.5 mmol/L. The Clinical
Chemistry laboratory at Skåne University Hospital
Malmö is accredited by Swedac (The Swedish Board for
Accreditation and Conformity Assessment) and takes
part in the external quality assurance program of Instand
e.V., Düsseldorf, Germany.
Statistical methods
Serum levels of 25OHD3 were normally distributed. The
cohort subjects were ranked into quartiles based on
serum levels of 25OHD3. Different quartiles of serum
25OHD3 were compared with regard to age at baseline
(continuous and as categories in five-year intervals), life-
style, BMI (continuous and categorical), menopausal sta-
tus, socio-demographic factors, season, biochemical vari-
ables, and dietary intakes.
Means of serum 25OHD3 were calculated in different
categories of all factors mentioned above. Confidence in-
tervals were chosen as an estimation of the accuracy of the
estimated means. In order to examine differences in mean
vitamin D concentrations between different categories of
the studied factors, ANOVA was used followed by a
Bonferroni t-test, thus multiplying the obtained p-values
with the number of comparisons. All tests were two-sided
and a p-value of 0.05 was considered statistically signifi-
cant. Missing values constituted less than 1% for all factors.
Serum 25OHD3 levels were dichotomized into low
(≤75 nmol/L) and high (>75 nmol/L), i.e., the cut-off in-
dicating the minimum level previously estimated to be
sufficient [30]. Odds ratios with 95% confidence intervals
(CI) were estimated for high versus low concentrations,
in relation to each of the studied factors, using a logistic
regression analysis. In a second model, the odds ratios
for high versus low concentrations were adjusted for
age, season and storage time. Age has previously been
related to vitamin D levels and there is a well-known
seasonal variation in vitamin D levels [31]. The potential
effect of biological degradation is not well known and
this justified the inclusion of storage time in the finalmodel. In a sensitivity analysis, a third model included
adjustment for total dietary vitamin D intake (entered as
quintiles).
The relation between different factors and 25OHD3
was further investigated using multiple linear regression
analysis. All categorical variables in the linear regression
analysis were recorded and entered as multiple categor-
ical variables with values as 0 or 1. Partial regression co-
efficients (βi) with 95% confidence intervals, adjusted for
age, season and storage time, were reported. All statis-
tical analyses were performed using SPSS version 17.0.
Results
In this cross-sectional study on 727 women, mean age at
blood sampling was 56.9 years (range: 41–73 years), 74%
were postmenopausal, 91% were born in Sweden, mean
BMI was 25.5 kg/m2 (SD: 16.61 – 50.19), and the mean
level of 25OHD3 was 88.3 nmol/L (SD: 18–173).
Co-variates used in the multivariate analyses, (i.e., age
at baseline, season and storage time), were all examined
in relation to 25OHD3 concentrations and presented
below. There was no significant association between
storage time and 25OHD3 concentrations. The odds of
high 25OHD3 concentration, adjusted for age and sea-
son, were for storage time as a continuous variable: 0.98
(0.87-1.09). The linear regression analysis showed an ad-
justed regression coefficient for storage time of −0.59
(−1.97 to 0.79). That is, there was no strong association
between storage time and 25OHD3 levels.
Age, life-style, menopausal status, season, and
socio-demographic factors
Vitamin D quartiles 3 and 4 were characterised by a
relatively large proportion of women >65 years old
Table 1. The positive association between age and high
vitamin D levels was confirmed with a trend of increase
in vitamin D levels observed in older women in the ana-
lyses of mean 25OHD3 in different age categories,
Table 2, and in the continuous linear regression analysis,
Table 3. There was also a positive association between
vitamin D levels and use of OC in all analyses, Tables 1,
2, and 3. Women with relatively high 25OHD3 levels
were less often overweight or obese, and this negative
association was also seen comparing mean levels in dif-
ferent BMI categories, Table 2, in the dichotomised
Table 4 Serum vitamin D quartiles in relation to biochemical parameters and dietary intake
Serum vitamin D quartile [nmol/L]
1 [18–69] n = 179 2 [70–86] n = 187 3 [87–104] n = 177 4 [105–173] n = 184 All n = 727
Column percent*
Albumin
1 (30.0–39.0) 30.2 25.7 26.0 23.4 26.3
2 (39.1–40.9) 21.2 24.6 20.3 23.9 22.6
3 (41.0–42.2) 22.9 26.7 31.6 20.1 25.3
4 (42.3–50.3) 22.9 22.5 21.5 32.1 24.8
Creatinine
1 (42–58) 30.2 27.8 26.0 20.1 26.0
2 (59–64) 22.3 24.6 24.3 21.2 23.1
3 (65–71) 28.5 24.6 23.2 24.5 25.2
4 (72–130) 16.2 22.5 26.0 33.7 24.6
Phosphate
1 (0.66–1.07) 29.6 21.4 24.9 23.9 24.9
2 (1.08–1.19) 29.6 26.7 24.9 19.0 25.0
3 (1.20–1.32) 23.5 20.3 28.8 24.5 24.2
4 (1.33–2.00) 14.5 31.0 20.9 32.1 24.8
PTH
1 (0.38–2.63) 22.3 17.6 26.0 33.7 24.9
2 (2.64–3.55) 18.4 27.3 29.9 22.3 24.5
3 (3.56–4.89) 23.5 28.3 21.5 25.0 24.6
4 (4.90–30.60) 34.1 25.1 22.6 18.5 25.0
Calcium
1 (2.18–2.34) 35.8 26.2 22.6 24.5 27.2
2 (2.35–2.38) 19.6 24.6 23.2 17.4 21.2
3 (2.39–2.44) 26.8 23.5 27.7 26.1 26.0
4 (2.45–2.77) 15.1 24.6 26.0 32.1 24.5
Vitamin D– dietary
1 (0.83–7.19) 30.2 16.6 15.8 17.4 19.9
2 (2.67–10.17) 21.8 21.4 16.9 20.1 20.1
3 (2.66–11.86) 15.6 25.1 21.5 17.4 19.9
4 (3.54–12.57) 19.0 17.1 21.5 22.8 20.1
5 (5.14–22.83) 13.4 19.8 24.3 22.3 19.9
Calcium– dietary
1 (275.8–1203.8) 21.8 19.3 16.9 21.7 19.9
2 (435.5–1712.1) 19.0 23.0 19.2 19.0 20.1
3 (460.7–1669.4) 17.3 18.7 23.7 20.1 19.9
4 (636.6–2399.4) 21.2 16.6 22.6 20.1 20.1
5 (779.5–2791.5) 20.7 22.5 17.5 19.0 19.9
Vitamin D–total**
1 (0.83–9.31) 31.8 16.0 16.9 15.2 19.9
2 (2.66–11.86) 20.7 25.7 12.4 21.2 20.1
3 (3.97–12.57) 18.4 18.2 23.2 20.1 19.9
4 (4.84–16.55) 12.8 20.9 24.3 22.3 20.1
5 (6.47–37.01) 16.2 19.3 23.2 21.2 19.9
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Table 4 Serum vitamin D quartiles in relation to biochemical parameters and dietary intake (Continued)
Calcium–total**
1 (275.8–1203.8) 22.9 18.7 15.8 22.3 19.9
2 (435.5–1712.1) 17.9 23.0 23.2 16.3 20.1
3 (532.6–2089.9) 18.4 19.8 20.9 20.7 19.9
4 (723.5–2399.4) 22.3 17.1 19.8 21.2 20.1
5 (782.7–2986.8) 18.4 21.4 20.3 19.6 19.9
* Due to missing values, percentages do not always add up to 100%. ** Intake from diet and supplements.
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analysis, Table 3.
The association between 25OHD3 and alcohol showed a
bimodal pattern where 25OHD3 quartiles 1 and 4 had the
highest percentage of high consumers (>30 g/day), Table 1.
Correspondingly, women who reported no alcohol con-
sumption or were high consumers had low 25OHD3 levels,
Table 2, and this pattern was confirmed in the dichotomised
analysis and in the continuous analysis, Table 3.
The highest concentration of 25OHD3 was seen during
the summer and in the autumn, Table 1. This was con-
firmed in both the logistic regression analysis and in the lin-
ear regression analysis, Table 3. Women with relatively low
vitamin D levels were more often born abroad, Table 1. This
association was confirmed in the dichotomised analysis and
in the continuous analysis, Table 3. Vitamin D was not as-
sociated with menopausal status, use of MHT, smoking sta-
tus, education and socio-economic index in this study.
Most results were similar following inclusion of dietary
intake of total vitamin D in the logistic regression ana-
lysis, but the OR s for oral contraception changed from
1.49 (1.04-2.13) to 1.40 (0.97-2.02), for Born in Sweden
from 0.44 (0.26-0.74) to 0.51 (0.30-0.89 and for meno-
pausal status from 1.22 (0.70-2.12) to 1.28 (0.72-2.25).
Biochemical variables
Women with relatively high 25OHD3 levels had more
often high albumin levels, Table 4, but the association
did not reach statistical significance when 25OHD3
levels were compared in different albumin quartiles,
Table 5, or in the dichotomised analysis, Table 6. How-
ever, there was a statistically significant positive associ-
ation in the linear regression analysis, Table 6. 25OHD3
was also positively associated with creatinine, phosphate
and calcium in all analyses, Tables 4, 5, and 6; although
the association was borderline significant concerning
phosphate in the adjusted dichotomised analysis, Table 6.
In all analyses, there was an inverse association between
25OHD3 and PTH concentrations, Tables 4, 5, and 6.
All crude and adjusted analyses were similar.
Dietary intake
High serum concentrations of 25OHD3 were associated
with a high intake of vitamin D, Table 4. This findingwas confirmed comparing 25OHD3 levels in different
categories of vitamin D intake, Table 5, and in both the
dichotomised and continuous analysis, Table 6. The use
of dietary intake of vitamin D from the diet alone, or
from diet and supplements, showed similar results. Con-
trary to this, there was no statistically significant associ-
ation between intake of Calcium and 25OHD3 levels,
Tables 4, 5, and 6.
Discussion
This cross-sectional study including 727 females found
that serum levels of 25OHD3 are positively associated
with age, oral contraceptive use, moderate alcohol con-
sumption, and blood collection during summer / autumn,
a high dietary intake of vitamin D and serum concentra-
tions of creatinine, phosphate and calcium. Serum levels
of 25OHD3 were inversely associated with obesity, being
born outside Sweden and with serum levels of PTH.
A positive association between serum levels of 25OHD3
and advanced age has previously also been reported by
Moan et al. [32]. However, others have found vitamin D
deficiency to be more prevalent among elderly people
[33], which could be caused by poor production in the
skin [34], decreased intestinal absorption [35], and/or im-
paired renal function [36]. A reason for the difference be-
tween our and most previous studies may be that the
current study only included females up until the age of
72 years, and deficiency related to high age may not be ap-
parent until later. Another possible reason to the results
seen in the present study may be that older women in this
cohort consume relatively more vitamin D. We found no
association between menopausal status and serum levels
of 25OHD3, although postmenopausal women had slightly
higher levels.
A positive association between the use of OC and
serum level of 25OHD3 was found in the present study
and there was also a tendency for a positive association
between MHT and high serum levels of 25OHD3. This
is in line with several previous studies on 25OHD3 in re-
lation to OC and other exogenous oestrogens [37-41]. A
potential explanation may be that oestrogen increases
the levels of 25OHD3-binding proteins [42].
We found no strong association between socioeco-
nomic status and serum levels of 25OHD3, although
Table 5 Mean serum vitamin D levels in relation to
biochemical parameters and dietary intake
Factor No. Mean (95% CI) T–test (p–value*) ANOVA (p–value)
Albumin
1 191 87.0 (82.5–91.6) Ref.
2 164 91.2 (86.4–95.9) 0.344
3 184 88.7 (84.1–93.3) 0.730
4 180 91.7 (87.0–96.4) 0.058 0.076
Creatinine
1 189 88.4 (84.0–92.9) Ref.
2 168 88.2 (83.5–92.8) 0.337
3 183 87.1 (82.2–91.9) 0.581
4 179 94.5 (89.8–99.2) 0.001 0.003
Phosphate
1 181 89.8 (84.3–95.3) Ref.
2 182 83.5 (79.3–87.8) 0.177
3 176 91.3 (86.7–95.8) 0.308
4 180 93.5 (89.1–97.8) 0.012 <0.001
PTH
1 181 95.3 (90.3–100.3) Ref.
2 178 89.7 (85.5–93.8) 0.035
3 179 89.0 (84.4–93.6) 0.029
4 182 84.5 (79.7–89.3) <0.001 0.002
Calcium
1 198 86.6 (82.1–91.1) Ref.
2 154 85.7 (81.0–90.3) 0.425
3 189 90.9 (86.1–95.8) 0.067
4 178 93.8 (89.2–98.3) <0.001 0.001
Vitamin D–dietary
1 145 81.1 (76.5 – 85.6) Ref.
2 146 86.7 (82.3 – 91.1) 0.08
3 145 88.3 (84.1 – 92.6) 0.02
4 146 92.1 (87.4 – 96.7) 0.001
5 145 93.1 (88.9 – 97.4) <0.001 0.001
Calcium–dietary
1 145 87.3 (82.7 – 91.9) Ref.
2 146 88.2 (83.8 – 92.6) 0.79
3 145 90.1 (85.7 – 94.6) 0.39
4 146 88.0 (83.4 – 92.7) 0.83
5 145 87.6 (83.4 – 91.9) 0.92 0.92
Vitamin D–total**
1 145 79.9 (75.3 – 84.6) Ref.
2 146 86.0 (81.8 – 90.2) 0.06
3 145 90.9 (86.2 – 95.7) 0.001
4 146 93.5 (89.2 – 97.8) <0.001
5 145 90.9 (86.7 – 95.0) 0.001 <0.001
Calcium–total**
1 145 87.6 (82.8 – 92.3) Ref.
2 146 87.4 (83.2 – 91.7) 0.97
Table 5 Mean serum vitamin D levels in relation to
biochemical parameters and dietary intake (Continued)
3 145 89.4 (84.8 – 94.0) 0.59
4 146 88.2 (83.6 – 92.8) 0.85
5 145 88.8 (84.7 – 92.9) 0.70 0.97
* Compared to reference (p-value). ** Intake from diet and supplements.
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with a non-manual vs. a manual employment.
The present study shows a positive association between
high serum levels of 25OHD3 and moderate alcohol con-
sumption, as opposed to high alcohol consumption and
zero consumption. This observation is in accordance with a
recent study finding that moderate alcohol consumers have
a relatively high intake of vitamin D as compared to zero-
consumers [43]. Differences with regard to dietary intake
may be an explanation behind the low vitamin D levels in
zero-consumers, for example vegetarians may have a rela-
tively low intake of vitamin D [44] and it is possible to
hypothesize that they consume less alcohol as compared to
other groups. In general, the concentration of vitamin D
has shown to be reduced among high consumers of alco-
hol. This could be due to a variation in the dietary intake of
vitamin D during different drinking periods with marked
reduction during hard-drinking weeks [45].
Another factor closely related to alcohol consumption
is smoking, but in the present study there was no associ-
ation between smoking habits and serum levels of
25OHD3, and smoking is not likely to explain the asso-
ciation seen in the present analysis.
We found that obesity was associated with relatively low
serum levels of 25OHD3 and this is similar with several
other studies [46-49]. A potential explanation is that poor
dietary habits are related to increased BMI [50], and this
may also lead to a lower intake of vitamin D in obese
women as shown by Tidwell et al. [51]. Adipose tissue
contains vitamin D receptors which hypothetically could
lead to a sequestration of serum levels of 25OHD3 in
obese individuals [52]. Moreover, obesity is more prevalent
among people with lower education level [53], and this
may be an indirect explanation for the results in this study
as women with a manual vs. non-manual work had
slightly lower serum levels of 25OHD3. However, educa-
tional levels per se as measured in the current study were
not associated with serum levels of 25OHD3.
Women born abroad had lower serum levels of 25OHD3
in our report. Different geographical locations [54] and
ethnic backgrounds [55,56] have, indeed, been correlated
to the vitamin D level. Possible explanations could be re-
lated to cultural tradition with traditional dress style other
than western dress [57], colour of the skin because darker
skin has less capacity to make vitamin D from sunlight
[58,59], or a genetic impact on serum vitamin D status
probably through the skin synthesis of vitamin D [60].
Table 6 Crude and adjusted odds ratios (OR) for high (> 75 nmol/L) vs. low (≤75 nmol/L) vitamin D levels, and
regression coefficients (βi) from multiple regression analysis, in relation to biochemical parameters and dietary intake
Factor Low (n) High (n) Crude OR (95% CI) Adjusted*OR (95% CI) βi (95% CI) Adjusted* βi \(95% CI)
Albumin
1 68 123 1.00 1.00 Baseline Baseline
2 50 114 1.26 (0.81–1.97) 1.15 (0.72– 1.83) 2.66 (–3.02 to 8.34) 1.55 (–3.92 to 7.02)
3 55 129 1.30 (0.84–2.00) 1.22 (0.78– 1.92) 0.94 (–4.57 to 6.45) 0.18 (–5.13 to 5.48)
4 56 124 1.22 (0.79–1.89) 1.27 (0.81– 2.00) 5.59 (0.05 to 11.13) 6.73 (1.39 to 12.1)
Creatinine
1 66 123 1.00 1.00 Baseline Baseline
2 55 113 1.10 (0.71– 1.71) 1.07 (0.68– 1.68) 2.40 (–3.23 to 8.02) 2.47 (–2.93 to 7.86)
3 69 114 0.89 (0.58–1.35) 0.84 (0.54– 1.30) 1.61 (–3.89 to 7.11) 1.38 (–3.90 to 6.66)
4 39 140 1.93 (1.21– 3.06) 1.70 (1.05– 2.76) 9.11 (3.58 to 14.6) 6.97 (1.57 to 12.4)
Phosphate
1 62 119 1.00 1.00 Baseline Baseline
2 69 113 0.85 (0.56–1.31) 0.75 (0.48– 1.18) −3.79 (–9.34 to 1.76) −4.71 (–10.0 to 0.58)
3 54 122 1.18 (0.76–1.83) 1.12 (0.71– 1.78) 3.04 (–2.56 to 8.64) 2.81 (–2.54 to 8.16)
4 44 136 1.61 (1.02–2.55) 1.54 (0.96– 2.48) 7.33 (1.77 to 12.9) 6.93 (1.63 to 12.2)
PTH
1 51 130 1.00 1.00 Baseline Baseline
2 45 133 1.16 (0.73–1.85) 1.26 (0.77– 2.05) −5.83 (–11.4 to –0.23) −4.76 (–10.1 to 0.62)
3 56 123 0.86 (0.55–1.36) 0.83 (0.52– 1.32) −6.28 (–11.9 to –0.70) −6.71 (–12.1 to –1.34)
4 77 105 0.54 (0.35–0.83) 0.59 (0.37– 0.93) −11.8 (–17.3 to –6.22) −9.96 (–15.3 to –4.61)
Calcium
1 80 118 1.00 1.00 Baseline Baseline
2 47 107 1.55 (0.99–2.41) 1.66 (1.04 –2.64) 2.19 (–3.50 to 7.88) 2.80 (–2.63 to 8.24)
3 57 132 1.57 (1.03–2.39) 1.64 (1.05– 2.54) 5.10 (–0.29 to 10.5) 5.79 (0.63 to 11.0)
4 45 133 2.00 (1.29–3.12) 2.18 (1.37– 3.47) 10.2 (4.78 to 15.7) 11.1 (5.79 to 16.3)
Vitamin D–dietary
1 68 77 1.00 1.00 Baseline Baseline
2 51 95 1.65 (1.03– 2.64) 1.70 (1.04– 2.78) 5.64 (–0.57 to 11.9) 5.35 (–0.64 to 11.3)
3 36 109 2.67 (1.63– 4.40) 2.92 (1.74– 4.91) 7.29 (1.07 to 13.5) 7.50 (1.50 to 13.5)
4 41 105 2.26 (1.39–3.68) 2.52 (1.51– 4.19) 11.0 (4.82 to 17.2) 11.5 (5.47 to 17.5)
5 38 107 2.28 (1.52–.07) 2.68 (1.58– 4.57) 12.1 (5.86 to 18.3) 11.8 (5.58 to 17.9)
Calcium–dietary
1 53 92 1.00 1.00 Baseline Baseline
2 48 98 1.18 (0.73–1.91) 1.20 (0.73– 1.99) 0.87 (–5.41 to 7.16) 0.90 (–5.16 to 6.95)
3 39 106 1.57 (0.95–2.58) 1.63 (0.97– 2.73) 2.79 (–3.51 to 9.08) 3.08 (–2.98 to 9.13)
4 46 100 1.25 (0.77–2.04) 1.36 (0.82– 2.27) 0.71 (–5.58 to 7.00) 1.26 (–4.81 to 7.34)
5 48 97 1.16 (0.72–1.89) 1.23 (0.74– 2.03) 0.30 (–6.00 to 6.60) 0.67 (–5.40 to 6.74)
Vitamin D–total**
1 70 75 1.00 1.00 Baseline Baseline
2 46 100 2.03 (1.26–3.27) 2.05 (1.25– 3.38) 6.08 (–0.12 to 12.3) 5.63 (–0.31 to 11.6)
3 39 106 2.54 (1.55–4.14) 3.01 (1.79– 5.05) 11.0 (4.80 to 17.2) 12.1 (6.09 to 18.0)
4 40 106 2.47 (1.52–4.03) 2.96 (1.76– 4.99) 13.5 (7.36 to 19.7) 14.8 (8.81 to 20.8)
5 39 106 2.54 (1.55– 4.14) 2.84 (1.69– 4.78) 10.9 (4.72 to 17.1) 11.5 (5.50 to 17.5)
Calcium–total**
1 55 90 1.00 1.00 Baseline Baseline
2 46 100 1.33 (0.82–2.16) 1.36 (0.82– 2.26) −0.13 (–6.42 to 6.15) −0.15 (–6.19 to 5.90)
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Table 6 Crude and adjusted odds ratios (OR) for high (> 75 nmol/L) vs. low (≤75 nmol/L) vitamin D levels, and
regression coefficients (βi) from multiple regression analysis, in relation to biochemical parameters and dietary intake
(Continued)
3 41 104 1.55 (0.95–2.54) 1.63 (0.97– 2.71) 1.82 (–4.48 to 8.12) 2.46 (–3.61 to 8.53)
4 49 97 1.21 (0.75–1.96) 1.34 (0.81– 2.22) 0.63 (–5.65 to 6.92) 1.68 (–4.39 to 7.75)
5 43 102 1.45 (0.89–2.37) 1.52 (0.91– 2.52) 1.22 (–5.07 to 7.52) 1.43 (–4.63 to 7.50)
* Adjusted for age, season and time in freezer for all factors in the table. ** Intake from diet and supplements.
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http://www.biomedcentral.com/1472-6874/13/33Another explaining factor is variation in vitamin D intake
between different ethnic groups as vitamin D intake is
comparatively high in Scandinavian countries [61]. In this
group ultraviolet light may not be the only key in the pre-
vention of different condition but the role of dietary vita-
min D intake, supplement vitamin D and calcium come
into play [62-64]. In our study, the highest levels of serum
25OHD3 were seen during the summer and in the autumn
and these are in agreement with previous studies [65-69].
This is also to be expected as during this season the solar
UV radiation reaches adequate levels to have a sufficient
vitamin D production (ibid).
We found a positive association between serum levels
of 25OHD3, creatinine, phosphate and calcium, and an
inverse association with PTH. This has also been seen in
other studies [70], and follows the à priori hypothesis
given the physiology for vitamin D metabolism. A suffi-
cient concentration of vitamin D [71], is essential for
bone mineralization and bone turnover [72] and to
maintain an optimal vitamin D level requires a close
physiological cooperation between vitamin D, calcium
and PTH levels [73,74].
The positive association between intake of vitamin D
and levels of 25OHD3 in this study was expected and
has also been reported by others [75,76]. There was no
strong association between calcium intake and levels of
25OHD3 and this has been reported by others [77].
Our study has several methodological strengths. Serum
samples were collected in a standardized way and stored
at −80°C, laboratory methods had low CVs, and there were
a relatively large number of subjects, i.e., good statistical
power. The inclusion of both life-style factors and bio-
chemical parameters are additional strengths. However,
some methodological questions need to be discussed. It
may be questioned whether it is appropriate to use a single
determination for levels of vitamin D. However, it is re-
assuring that a recent cohort study that measured
25OHD3 at 2 times, 3 years apart, found a high correl-
ation between levels. Information on life-style and diet
was collected using various questionnaires and this may
lead to misclassification. However, validity and reproduci-
bility is high for both the socioeconomic questionnaire
and the dietary assessment method [23,25].
The results were adjusted for age, season and storage
time, and these factors ought not to have confounded
the results. It was considered appropriate to adjust onlyfor these factors, as we wanted to identify groups with low
vs. high vitamin D levels, rather than to determine what
factors that affected vitamin D levels the most. Concer-
ning dietary factors, the residual method was used, which
takes into account differences with regard to total energy
intake, i.e. the amount of the total dietary intake.
A valid question is whether the associations observed
in this cohort can be representative of the whole popula-
tion. Although in this study only 40% of the populations
have participated and as we have no information about
exposure to the studied risk factors in women outside
this cohort, observed means and the prevalence for stud-
ied factors may not be applicable to all age groups or to
the general population. However, as there was a wide
distribution of 25OHD3 and other determinants, it was
possible to make internal comparisons between subjects.
We consider that our estimations of odds ratios were
less sensitive to a potential selection bias.
Conclusions
The present population-based cohort study including 727
females found a positive association between serum levels
of 25OHD3 and age, oral contraceptive use, moderate al-
cohol consumption, blood collection during summer/ au-
tumn, creatinine, phosphate, calcium, and a high intake of
vitamin D. Low vitamin D levels were associated with
obesity, being born outside Sweden and high PTH levels.
The study may have implications e. g. for dietary recom-
mendations. However, the analysis is a cross-sectional
study and it is difficult to suggest lifestyle recommenda-
tions as cause- effect relationships are not clear.
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